$0
$156 Million
0.08% of portfolio
6,525
Q2 2025
Added 21.06%
$0
$149 Million
0.08% of portfolio
3,285
Q2 2025
Added 1.26%
$0
$146 Million
0.08% of portfolio
1,324
Q2 2025
Reduced 8.31%
$0
$145 Million
0.08% of portfolio
3,644
Q2 2025
Reduced 72.95%
$0
$160 Million
0.08% of portfolio
1,742
Q2 2025
Reduced 84.58%
$75.5B
$145 Million
0.08% of portfolio
781
Q2 2025
Added 72.03%
$255B
$160 Million
0.08% of portfolio
2,253
Q2 2025
Reduced 46.98%
$18.9B
$148 Million
0.08% of portfolio
4,690
Q2 2025
Added 7.08%
$0
$156 Million
0.08% of portfolio
1,469
Q2 2025
Reduced 8.02%
$0
$160 Million
0.08% of portfolio
1,103
Q2 2025
Reduced 94.94%
$0
$148 Million
0.08% of portfolio
2,991
Q2 2025
Reduced 32.07%
-
$127 Million
0.07% of portfolio
-
Q2 2025
Added 8.85%
Blackstone Private Credit Fund Class D
-
$130 Million
0.07% of portfolio
-
Q2 2025
Reduced 52.94%
Celestica Inc Sub Vtg Shs
-
$133 Million
0.07% of portfolio
-
Q2 2025
New
-
$128 Million
0.07% of portfolio
-
Q2 2025
Added 602.0%
$45.6B
$139 Million
0.07% of portfolio
13,075
Q2 2025
Reduced 30.71%
$148B
$139 Million
0.07% of portfolio
1,288
Q2 2025
Reduced 56.01%
Glaxo Smith Kline PLC Adr
-
$128 Million
0.07% of portfolio
-
Q2 2025
Reduced 2.12%
$0
$139 Million
0.07% of portfolio
3,046
Q4 2024
New
$0
$138 Million
0.07% of portfolio
3,568
Q2 2025
Added 93.18%
$117B
$141 Million
0.07% of portfolio
1,835
Q4 2024
New
$0
$128 Million
0.07% of portfolio
956
Q2 2025
Reduced 46.83%
$0
$134 Million
0.07% of portfolio
1,204
Q2 2025
Added 0.08%
$0
$139 Million
0.07% of portfolio
773
Q2 2025
Reduced 10.01%
$0
$128 Million
0.07% of portfolio
594
Q2 2025
Added 33.18%
$0
$125 Million
0.07% of portfolio
1,363
Q2 2025
Reduced 38.63%
$0
$124 Million
0.07% of portfolio
674
Q2 2025
Reduced 63.76%
$0
$128 Million
0.07% of portfolio
3,375
Q2 2025
Added 209.07%
$132B
$132 Million
0.07% of portfolio
289
Q2 2025
Reduced 73.36%
$0
$141 Million
0.07% of portfolio
1,407
Q2 2025
Reduced 11.45%
Range Nuclear Renaissance ETF
-
$126 Million
0.07% of portfolio
-
Q2 2025
New
-
$139 Million
0.07% of portfolio
-
Q2 2025
Added 205.71%
$0
$140 Million
0.07% of portfolio
2,643
Q2 2025
New
$158B
$105 Million
0.06% of portfolio
273
Q2 2025
Reduced 31.06%
$156B
$110 Million
0.06% of portfolio
395
Q2 2025
Reduced 94.96%
$113B
$113 Million
0.06% of portfolio
1,247
Q2 2025
Reduced 20.62%
$150B
$112 Million
0.06% of portfolio
323
Q2 2025
Reduced 14.55%
$0
$123 Million
0.06% of portfolio
1,366
Q2 2025
Reduced 75.52%
$91.8B
$123 Million
0.06% of portfolio
421
Q1 2025
Added 8.79%
$0
$111 Million
0.06% of portfolio
1,040
Q2 2025
New
$0
$121 Million
0.06% of portfolio
2,381
Q2 2025
Added 1.23%
$0
$114 Million
0.06% of portfolio
2,300
Q2 2025
Added 360.0%
$61.5B
$117 Million
0.06% of portfolio
4,044
Q2 2025
Reduced 50.17%
$31.1B
$110 Million
0.06% of portfolio
1,358
Q2 2025
Reduced 17.2%
$139B
$113 Million
0.06% of portfolio
4,642
Q2 2025
Reduced 46.89%
Roundhill Magnificent Seven ETF
-
$115 Million
0.06% of portfolio
-
Q2 2025
Reduced 25.94%
-
$124 Million
0.06% of portfolio
-
Q2 2025
Added 207.38%
Strive Total Return Bond ETF
-
$120 Million
0.06% of portfolio
-
Q2 2025
Added 207.54%
$0
$112 Million
0.06% of portfolio
287
Q1 2025
Reduced 7.72%
$87.2B
$116 Million
0.06% of portfolio
610
Q2 2025
Added 19.61%